The predictive role of interim pet-ct in the treatment of hodgkin's lymphoma in children
- 作者: Kulichkina N1, Belyaeva E1, Popa A1, Valiev T1, Odzharova A1, Mentkevich G1
-
隶属关系:
- N.N.Blokhin National Medical Reseach Center of Oncology of the Ministry of Health of the Russian Federation
- 期: 卷 19, 编号 3 (2017)
- 页面: 52-56
- 栏目: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/27152
- ID: 27152
如何引用文章
全文:
详细
作者简介
N Kulichkina
N.N.Blokhin National Medical Reseach Center of Oncology of the Ministry of Health of the Russian Federation
Email: Natalia_kulichkina@maiLru
врач - детский онколог отд-ния химиотерапии гемобластозов НИИ детской онкологии и гематологии 115478, Russian Federation, Moscow, Kashirskoye sh., d. 23
E Belyaeva
N.N.Blokhin National Medical Reseach Center of Oncology of the Ministry of Health of the Russian Federationканд. мед. наук, врач - детский онколог отд-ния химиотерапии гемобластозов НИИ детской онкологии и гематологии 115478, Russian Federation, Moscow, Kashirskoye sh., d. 23
A Popa
N.N.Blokhin National Medical Reseach Center of Oncology of the Ministry of Health of the Russian Federationд-р мед. наук, проф., зав. отд-нием химиотерапии гемобластозов НИИ детской онкологии и гематологии 115478, Russian Federation, Moscow, Kashirskoye sh., d. 23
T Valiev
N.N.Blokhin National Medical Reseach Center of Oncology of the Ministry of Health of the Russian Federationд-р мед. наук, ст. науч. сотр. отд-ния химиотерапии гемобластозов НИИ детской онкологии и гематологии 115478, Russian Federation, Moscow, Kashirskoye sh., d. 23
A Odzharova
N.N.Blokhin National Medical Reseach Center of Oncology of the Ministry of Health of the Russian Federationканд. мед. наук, ст. науч. сотр. отд-ния позитронно-эмиссионной томографии НИИ детской онкологии и гематологии 115478, Russian Federation, Moscow, Kashirskoye sh., d. 23
G Mentkevich
N.N.Blokhin National Medical Reseach Center of Oncology of the Ministry of Health of the Russian Federationд-р мед. наук, проф., зам. дир. по лечебной и научной работе НИИ детской онкологии, зав. отд-нием химиотерапии и трансплантации костного мозга 115478, Russian Federation, Moscow, Kashirskoye sh., d. 23
参考
- Cheson B.D, Fisher R.I, Barrington S.F. et al. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification. J Clin Oncol 2014; 32:3059-67.
- Barrington S.F, Mikhaeel N.G, Kostakoglu L et al. Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 2014; 32:3 0-48-58.
- Engert A, Haverkamp H, Kobe C et al. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin’s lymphoma (HD15 trial): A randomised, open-label,phase 3 non-inferiority trial Lancet 2012; 379:1791 -9.
- Thomson K.J, Kayani I, Ardeshna K. et al. A response-adjusted PETba- sed transplantation strategy in primary resistant and relapsed Hodgkin lymphoma. Leukemia 2013; 27:1419-22.
- Hutchings M. FDG-PET response-adapted therapy: is 18F-fluorodeo- xyglucose positron emission tomography a safe predictor for a change of therapy? Hematol Oncol Clin N Am 2014; 28 (1): 87-103.
- Radford J, Barringjon S, Cournell N. et al. Involved field radiotherapy vs no further treatment in patients with clinical stages IA and IIA Hodgkin lymphoma and a negative’ PET scan after 3 cycles ABVD: results of the UKNCRIRAPID trial. Blood2012; 120 (21): 54J.
- Беляева Е.С. Современные подходы к лечению детей с распространенными стадиями лимфомы Ходжкина. Автореф. дис.. канд. мед. наук. М., 2009.
- Gallamini A, Hutchings M., Rigacci L et al. Early interim 2-[18F]f uoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin’s lymphoma: a report from a joint Italian-Danish study. J Clin Oncology 2007; 25 (24): 3746-52.
- Oki Y, Chuang H, Chasen B. et al. The prognostic value of interim positron emission tomography scans in patients with classical Hodgkin lymphoma. Br Haematology 2014; 165 (1): 112-16.
- Furth C., Steffen Ingo G., Amthauer H. et al. Early and Late Therapy Response Assessment With 18-Fluorodeoxyglucose Positron Emission Tomography in Pediatric Hodgkin’s Lymphoma: Analysis of a Prospective Multicenter Trial] Clin Oncology 2009; 27 (26): 4385-91.
- Gallamini A, Barringtom S, Biggi A. et al. The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauvillefive-point scale. Haematologica 2014; 99 (6): 1107-13.